Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022 Featured Updates to the NCCN Guidelines

被引：53

作者：

Wierda, William G. ^{[1
]}

Brown, Jennifer ^{[2
]}

Abramson, Jeremy S. ^{[3
]}

Awan, Farrukh ^{[4
]}

Bilgrami, Syed F. ^{[5
]}

Bociek, Greg ^{[6
]}

Brander, Danielle ^{[7
]}

Chanan-Khan, Asher A. ^{[8
]}

Coutre, Steve E. ^{[9
]}

Davis, Randall S. ^{[10
]}

Eradat, Herbert ^{[11
]}

Fletcher, Christopher D. ^{[12
]}

Gaballa, Sameh ^{[13
]}

Ghobadi, Armin ^{[14
,15
]}

Hamid, Muhammad Saad ^{[16
]}

Hernandez-Ilizaliturri, Francisco ^{[17
]}

Hill, Brian ^{[18
,19
]}

Kaesberg, Paul ^{[20
]}

Kamdar, Manali ^{[21
]}

Kaplan, Lawrence D. ^{[22
]}

Khan, Nadia ^{[23
]}

Kipps, Thomas J. ^{[24
]}

Ma, Shuo ^{[25
]}

Mato, Anthony ^{[26
]}

Mosse, Claudio ^{[27
]}

Schuster, Stephen ^{[28
]}

Siddiqi, Tanya ^{[29
]}

Stephens, Deborah M. ^{[30
]}

Ujjani, Chaitra ^{[31
]}

Wagner-Johnston, Nina ^{[32
]}

Woyach, Jennifer A. ^{[33
]}

Ye, J. Christine ^{[34
]}

Dwyer, Mary A. ^{[35
]}

Sundar, Hema ^{[35
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[3] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA

[4] UT Southwestern Simmons Comprehens Canc Ctr, Dallas, TX USA

[5] Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA

[6] Fred & Pamela Buffett Canc Ctr, Omaha, NE USA

[7] Duke Canc Inst, Durham, NC USA

[8] Mayo Clin, Canc Ctr, Rochester, MN USA

[9] Stanford Canc Inst, Stanford, CA USA

[10] ONeal Comprehens Canc Ctr UAB, Birmingham, AL USA

[11] UCLA, Jonsson Comprehens Canc Ctr, Los Angeles, CA USA

[12] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA

[13] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[14] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO 63110 USA

[15] Washington Univ, Sch Med, St Louis, MO USA

[16] Univ Tennessee, Hlth Sci Ctr, St Jude Chidrens Res Hosp, Knoxville, TN 37996 USA

[17] Roswel Pk Comprehens Canc Ctr, Buffalo, NY USA

[18] Univ Hosp Seidman Canc Ctr, Case Comprehensve Canc Ctr, Cleveland, OH USA

[19] Cleveland Clin, Tausslg Canc Inst, Cleveland, OH 44106 USA

[20] UC Davis Comprehens Canc Ctr, Davis, CA USA

[21] Univ Colorado, Canc Ctr, Boulder, CO 80309 USA

[22] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[23] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[24] UC San Diego Moores Canc Ctr, San Diego, CA USA

[25] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[26] Mem Sloan Kettering Canc Ctr, Ithaca, NY USA

[27] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[28] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[29] City Hope Natl Med Ctr, Duarte, CA USA

[30] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[31] Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, 1124 Columbia St, Seattle, WA 98104 USA

[32] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA

[33] Ohio State Univ, Comprehenslve Canc Ctr, James Canc Hosp & Solove Res Inst, Columbus, OH 43210 USA

[34] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA

[35] Natl Comprehens Canc Network, Philadelphia, PA USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2022年 / 20卷 / 06期

关键词：

MINIMAL RESIDUAL DISEASE; CHLORAMBUCIL PLUS OBINUTUZUMAB; FLOW-CYTOMETRY; OPEN-LABEL; 1ST-LINE TREATMENT; FOLLOW-UP; PHASE-II; IBRUTINIB; VENETOCLAX; CLL;

D O I：

10.6004/jnccn.2022.0031

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The treatment landscape of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) has significantly evolved in recent years. Targeted therapy with Bruton???s tyrosine kinase (BTK) inhibitors and BCL-2 inhibitors has emerged as an effective chemotherapy-free option for patients with previously untreated or relapsed/refractory CLL/SLL. Undetectable minimal residual disease after the end of treatment is emerging as an important predictor of progression-free and overall survival for patients treated with fixed-duration BCL-2 inhibitor-based treatment. These NCCN Guidelines Insights discuss the updates to the NCCN Guidelines for CLL/ SLL specific to the use of chemotherapy-free treatment options for patients with treatment-na??ve and relapsed/refractory disease.

引用

页码：622 / 634

页数：13

共 50 条

[1] NCCN Guidelines® Insights Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017 Featured Updates to the NCCN Guidelines
Wierda, William G.
Zelenetz, Andrew D.
Gordon, Leo I.
Abramson, Jeremy S.
Advani, Ranjana H.
Andreadis, C. Babis
Bartlett, Nancy
Byrd, John C.
Caimi, Paolo
Fayad, Luis E.
Fisher, Richard I.
Glenn, Martha J.
Habermann, Thomas M.
Harris, Nancy Lee
Hernandez-Ilizaliturri, Francisco
Hoppe, Richard T.
Horwitz, Steven M.
Kaminski, Mark S.
Kelsey, Christopher R.
Kim, Youn H.
Krivacic, Susan
LaCasce, Ann S.
Martin, Michael G.
Nademanee, Auayporn
Porcu, Pierluigi
Press, Oliver
Rabinovitch, Rachel
Reddy, Nishitha
Reid, Erin
Roberts, Kenneth
Saad, Ayman A.
Snyder, Erin D.
Sokol, Lubomir
Swinnen, Lode J.
Vose, Julie M.
Yahalom, Joachim
Dwyer, Mary A.
Sundar, Hema
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (03): : 293 - 311
[2] NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019
Wierda, William G.
Byrd, John C.
Abramson, Jeremy S.
Bilgrami, Syed F.
Bociek, Greg
Brander, Danielle
Brown, Jennifer
Chanan-Khan, Asher A.
Chavez, Julio C.
Coutre, Steve E.
Davis, Randall S.
Fletcher, Christopher D.
Hill, Brian
Kahl, Brad S.
Kamdar, Manali
Kaplan, Lawrence D.
Khan, Nadia
Kipps, Thomas J.
Ma, Shuo
Malek, Sami
Mato, Anthony
Mosse, Claudio
Neppalli, Vishala T.
Shadman, Mazyar
Siddiqi, Tanya
Stephens, Deborah
Wagner, Nina
Dwyer, Mary A.
Sundar, Hema
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (01): : 12 - 20
[3] Multiple Myeloma, Version 3.2022 Featured Updates to the NCCN Guidelines
Callander, Natalie S.
Baljevic, Muhamed
Adekola, Kehinde
Anderson, Larry D.
Campagnaro, Erica
Castillo, Jorge J.
Costello, Caitlin
Devarakonda, Srinivas
Elsedawy, Noura
Faiman, Matthew
Garfall, Alfred
Godby, Kelly
Hillengass, Jens
Holmberg, Leona
Htut, Myo
Huff, Carol Ann
Hultcrantz, Malin
Kang, Yubin
Larson, Sarah
Liedtke, Michaela
Martin, Thomas
Omel, James
Sborov, Douglas
Shain, Kenneth
Stockerl-Goldstein, Keith
Weber, Donna
Berardi, Ryan A.
Kumar, Rashmi
Kumar, Shaji K.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (01): : 9 - 19
[4] Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma, Version 2.2024
Wierda, William G.
Brown, Jennifer
Abramson, Jeremy S.
Awan, Farrukh
Bilgrami, Syed F.
Bociek, Greg
Brander, Danielle
Cortese, Matthew
Cripe, Larry
Davis, Randall S.
Eradat, Herbert
Fakhri, Bita
Fletcher, Christopher D.
Gaballa, Sameh
Hamid, Muhammad Saad
Hill, Brian
Kaesberg, Paul
Kahl, Brad
Kamdar, Manali
Kipps, Thomas J.
Ma, Shuo
Mosse, Claudio
Nakhoda, Shazia
Parikh, Sameer
Schorr, Andrew
Schuster, Stephen
Seshadri, Madhav
Siddiqi, Tanya
Stephens, Deborah M.
Thompson, Meghan
Ujjani, Chaitra
Valdez, Riccardo
Wagner-Johnston, Nina
Woyach, Jennifer A.
Sundar, Hema
Dwyer, Mary
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (03): : 175 - 204
[5] Hodgkin Lymphoma, Version 2.2022 Featured Updates to the NCCN Guidelines
Hoppe, Richard T.
Advani, Ranjana H.
Ai, Weiyun Z.
Ambinder, Richard F.
Armand, Philippe
Bello, Celeste M.
Benitez, Cecil M.
Chen, Weina
Dabaja, Bouthaina
Daly, Megan E.
Gordon, Leo I.
Hansen, Neil
Herrera, Alex F.
Hochberg, Ephraim P.
Johnston, Patrick B.
Kaminski, Mark S.
Kelsey, Christopher R.
Kenkre, Vaishalee P.
Khan, Nadia
Lynch, Ryan C.
Maddocks, Kami
McConathy, Jonathan
Metzger, Monika
Morgan, David
Mulroney, Carolyn
Pullarkat, Sheeja T.
Rabinovitch, Rachel
Rosenspire, Karen C.
Seropian, Stuart
Tao, Randa
Torka, Pallawi
Winter, Jane N.
Yahalom, Joachim
Yang, Joanna C.
Burns, Jennifer L.
Campbell, Mallory
Sundar, Hema
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (04): : 323 - 334
[6] Updates in the management of chronic lymphocytic leukemia/small lymphocytic leukemia
Hanna, Kirollos S.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (01) : 146 - 155
[7] Acute Lymphoblastic Leukemia, Version 1.2019 Featured Updates to the NCCN Guidelines
Brown, Patrick A.
Wieduwilt, Matthew
Logan, Aaron
DeAngelo, Daniel J.
Wang, Eunice S.
Fathi, Amir
Cassaday, Ryan D.
Litzow, Mark
Advani, Anjali
Aoun, Patricia
Bhatnagar, Bhavana
Boyer, Michael W.
Bryan, Teresa
Burke, Patrick W.
Coccia, Peter F.
Coutre, Steven E.
Jain, Nitin
Kirby, Suzanne
Liu, Arthur
Massaro, Stephanie
Mattison, Ryan J.
Oluwole, Olalekan
Papadantonakis, Nikolaos
Park, Jae
Rubnitz, Jeffrey E.
Uy, Geoffrey L.
Gregory, Kristina M.
Ogba, Ndiya
Shah, Bijal
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (05): : 414 - 423
[8] Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020
Wierda, William G.
Byrd, John C.
Abramson, Jeremy S.
Bilgrami, Syed F.
Bociek, Greg
Brander, Danielle
Brown, Jennifer
Chanan-Khan, Asher A.
Chavez, Julio C.
Coutre, Steve E.
Davis, Randall S.
Fletcher, Christopher D.
Hill, Brian
Kahl, Brad S.
Kamdar, Manali
Kaplan, Lawrence D.
Khan, Nadia
Kipps, Thomas J.
Lim, Megan S.
Ma, Shuo
Malek, Sami
Mato, Anthony
Mosse, Claudio
Shadman, Mazyar
Siddiqi, Tanya
Stephens, Deborah
Sundaram, Suchitra
Wagner, Nina
Dwyer, Mary
Sundar, Hema
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (02): : 185 - 217
[9] NCCN Guidelines® Insights Melanoma, Version 3.2016 Featured Updates to the NCCN Guidelines
Coit, Daniel G.
Thompson, John A.
Algazi, Alain
Andtbacka, Robert
Bichakjian, Christopher K.
Carson, William E., III
Daniels, Gregory A.
DiMaio, Dominick
Fields, Ryan C.
Fleming, Martin D.
Gastman, Brian
Gonzalez, Rene
Guild, Valerie
Johnson, Douglas
Joseph, Richard W.
Lange, Julie R.
Martini, Mary C.
Materin, Miguel A.
Olszanski, Anthony J.
Ott, Patrick
Gupta, Aparna Priyanath
Ross, Merrick I.
Salama, April K.
Skitzki, Joseph
Swetter, Susan M.
Tanabe, Kenneth K.
Torres-Roca, Javier F.
Trisal, Vijay
Urist, Marshall M.
McMillian, Nicole
Engh, Anita
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (08): : 945 - 958
[10] Melanoma, Version 4.2014 Featured Updates to the NCCN Guidelines
Coit, Daniel G.
Thompson, John A.
Andtbacka, Robert
Anker, Christopher J.
Bichakjian, Christopher K.
Carson, William E., III
Daniels, Gregory A.
Daud, Adil
DiMaio, Dominick
Fleming, Martin D.
Gonzalez, Rene
Guild, Valerie
Halpern, Allan C.
Hodi, Stephen, Jr.
Kelley, Mark C.
Khushalani, Nikhil I.
Kudchadkar, Ragini R.
Lange, Julie R.
Martini, Mary C.
Olszanski, Anthony J.
Ross, Merrick I.
Salama, April
Swetter, Susan M.
Tanabe, Kenneth K.
Trisal, Vijay
Urist, Marshall M.
McMillian, Nicole R.
Ho, Maria
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2014, 12 (05): : 621 - 629

← 1 2 3 4 5 →